OBJECTIVES: To identify infants with hyperinsulinism caused by defects of the beta-cell adenosine triphosphate-dependent potassium channel complex and to distinguish focal and diffuse forms of hyperinsulinism caused by these mutations. STUDY DESIGN: The acute insulin response to intravenous calcium stimulation (CaAIR) was determined in 9 patients <20 years with diffuse hyperinsulinism caused by defective beta-cell sulfonylurea receptor (SUR1(-/-)), 3 patients with focal congenital hyperinsulinism (6 weeks to 18 months), a 10-year-old with insulinoma, 5 with hyperinsulinism/hyperammonemia syndrome caused by defective glutamate dehydrogenase (6 months to 28 years), 4 SUR1(+/-) heterozygotes with no symptoms, and 9 normal adults. Three infants with congenital focal disease, 1 with diffuse hyperinsulinism, and the child with insulinoma underwent selective pancreatic intra-arterial calcium stimulation with hepatic venous sampling. RESULTS: Children with diffuse SUR1(-/-) disease and infants with congenital focal hyperinsulinism responded to CaAIR, whereas the normal control group, patients with hyperinsulinism/hyperammonemia syndrome, and SUR1(+/-) carriers did not. Selective arterial calcium stimulation of the pancreas with hepatic venous sampling revealed selective, significant step-ups in insulin secretion that correlated anatomically with the location of solitary lesions confirmed surgically in 2 of 3 infants with congenital focal disease and in the child with insulinoma. Selective arterial calcium stimulation of the pancreas with hepatic venous sampling demonstrated markedly elevated baseline insulin levels throughout the pancreas of the infant with diffuse hyperinsulinism. CONCLUSIONS: The intravenous CaAIR is a safe and simple test for identifying infants with diffuse SUR1(-/-) hyperinsulinism or with focal congenital hyperinsulinism. Preoperative selective arterial calcium stimulation of the pancreas with hepatic venous sampling can localize focal lesions causing hyperinsulinism in children. The combination of these calcium stimulation tests may help distinguish focal lesions suitable for cure by local surgical resection.
OBJECTIVES: To identify infants with hyperinsulinism caused by defects of the beta-cell adenosine triphosphate-dependent potassium channel complex and to distinguish focal and diffuse forms of hyperinsulinism caused by these mutations. STUDY DESIGN: The acute insulin response to intravenous calcium stimulation (CaAIR) was determined in 9 patients <20 years with diffuse hyperinsulinism caused by defective beta-cell sulfonylurea receptor (SUR1(-/-)), 3 patients with focal congenital hyperinsulinism (6 weeks to 18 months), a 10-year-old with insulinoma, 5 with hyperinsulinism/hyperammonemia syndrome caused by defective glutamate dehydrogenase (6 months to 28 years), 4 SUR1(+/-) heterozygotes with no symptoms, and 9 normal adults. Three infants with congenital focal disease, 1 with diffuse hyperinsulinism, and the child with insulinoma underwent selective pancreatic intra-arterial calcium stimulation with hepatic venous sampling. RESULTS:Children with diffuse SUR1(-/-) disease and infants with congenital focal hyperinsulinism responded to CaAIR, whereas the normal control group, patients with hyperinsulinism/hyperammonemia syndrome, and SUR1(+/-) carriers did not. Selective arterial calcium stimulation of the pancreas with hepatic venous sampling revealed selective, significant step-ups in insulin secretion that correlated anatomically with the location of solitary lesions confirmed surgically in 2 of 3 infants with congenital focal disease and in the child with insulinoma. Selective arterial calcium stimulation of the pancreas with hepatic venous sampling demonstrated markedly elevated baseline insulin levels throughout the pancreas of the infant with diffuse hyperinsulinism. CONCLUSIONS: The intravenous CaAIR is a safe and simple test for identifying infants with diffuse SUR1(-/-) hyperinsulinism or with focal congenital hyperinsulinism. Preoperative selective arterial calcium stimulation of the pancreas with hepatic venous sampling can localize focal lesions causing hyperinsulinism in children. The combination of these calcium stimulation tests may help distinguish focal lesions suitable for cure by local surgical resection.
Authors: S Owada; O Larsson; P Arkhammar; A I Katz; A V Chibalin; P O Berggren; A M Bertorello Journal: J Biol Chem Date: 1999-01-22 Impact factor: 5.157
Authors: C A Stanley; Y K Lieu; B Y Hsu; A B Burlina; C R Greenberg; N J Hopwood; K Perlman; B H Rich; E Zammarchi; M Poncz Journal: N Engl J Med Date: 1998-05-07 Impact factor: 91.245
Authors: L Beccaria; L Bosio; G Burgio; P L Paesano; A Del Maschio; G Chiumello Journal: J Pediatr Endocrinol Metab Date: 1997 May-Jun Impact factor: 1.634
Authors: A Nestorowicz; N Inagaki; T Gonoi; K P Schoor; B A Wilson; B Glaser; H Landau; C A Stanley; P S Thornton; S Seino; M A Permutt Journal: Diabetes Date: 1997-11 Impact factor: 9.461
Authors: J Rahier; C Sempoux; J C Fournet; F Poggi; F Brunelle; C Nihoul-Fekete; J M Saudubray; F Jaubert Journal: Histopathology Date: 1998-01 Impact factor: 5.087
Authors: J L Doppman; R Chang; D L Fraker; J A Norton; H R Alexander; D L Miller; E Collier; M C Skarulis; P Gorden Journal: Ann Intern Med Date: 1995-08-15 Impact factor: 25.391
Authors: A Kelly; D Ng; R J Ferry; A Grimberg; S Koo-McCoy; P S Thornton; C A Stanley Journal: J Clin Endocrinol Metab Date: 2001-08 Impact factor: 5.958
Authors: Sara E Pinney; Courtney MacMullen; Susan Becker; Yu-Wen Lin; Cheryl Hanna; Paul Thornton; Arupa Ganguly; Show-Ling Shyng; Charles A Stanley Journal: J Clin Invest Date: 2008-08 Impact factor: 14.808
Authors: N Scott Adzick; Diva D De Leon; Lisa J States; Katherine Lord; Tricia R Bhatti; Susan A Becker; Charles A Stanley Journal: J Pediatr Surg Date: 2018-10-05 Impact factor: 2.545
Authors: Jean-Marc Guettier; Anthony Kam; Richard Chang; Monica C Skarulis; Craig Cochran; H Richard Alexander; Steven K Libutti; James F Pingpank; Phillip Gorden Journal: J Clin Endocrinol Metab Date: 2009-02-03 Impact factor: 5.958
Authors: Björn A Blomberg; Mateen C Moghbel; Babak Saboury; Charles A Stanley; Abass Alavi Journal: Mol Imaging Biol Date: 2013-02 Impact factor: 3.488
Authors: Samir Sayed; David R Langdon; Stella Odili; Pan Chen; Carol Buettger; Alisa B Schiffman; Mariko Suchi; Rebecca Taub; Joseph Grimsby; Franz M Matschinsky; Charles A Stanley Journal: Diabetes Date: 2009-03-31 Impact factor: 9.461